Literature DB >> 31372932

Temporary ventricular assist device implantation by sternotomy-avoiding technique for bridge-to-decision therapy: a comparison with conventional implantation.

Masatoshi Akiyama1, Konosuke Sasaki2, Satoshi Kawatsu2, Yusuke Suzuki2, Tomoyuki Suzuki2, Ichiro Yoshioka2, Goro Takahashi2, Kiichiro Kumagai2, Osamu Adachi2, Yoshikatsu Saiki2.   

Abstract

OBJECTIVE: Temporary ventricular assist device (VAD) is a commonly used therapeutic option for cardiogenic shock. Patients requiring this treatment are often critical, and clinical outcomes remain unsatisfactory. This study evaluated the feasibility and efficacy of a sternotomy-avoiding technique for temporary VAD implantation to improve patient outcomes.
METHODS: Between December 2012 and November 2018, seven patients underwent temporary VAD implantation by sternotomy-avoiding technique (SA group) and eight by median sternotomy technique (MS group). Pre- and intraoperative characteristics, postoperative 7-day hemodynamic parameters, 30-day mortality, and adverse events were compared between the groups.
RESULTS: More than 50% of the patients were mechanically supported before temporary VAD implantation. Cardiopulmonary bypass time was significantly shorter in the SA than in the MS group (84 min vs 215 min; p = 0.011); surgical time tended to be shorter in the SA group (385 min vs 461 min; p = 0.064). Pump index, cardiac index, mixed venous oxygen saturation, and central venous pressure did not differ significantly during the first seven days of support. The 30-day incidence of any adverse event was not significantly different between the groups. No patients in the SA group needed re-exploration for surgical bleeding. Thirty-day all-cause mortality rates were 29% in the SA group and 0% in the MS group (p = 0.11).
CONCLUSIONS: The sternotomy-avoiding and conventional techniques resulted in comparable short-term hemodynamic support. The sternotomy-avoiding technique was associated with a potential reduction in risk of re-exploration for bleeding. These results support the usefulness of the sternotomy-avoiding procedure for selected patients.

Entities:  

Keywords:  Bridge to decision; Cardiogenic shock; Temporary ventricular assist device

Year:  2019        PMID: 31372932     DOI: 10.1007/s11748-019-01185-5

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  13 in total

1.  Is it Possible to Implant HeartMate 3 Less Invasively? New Pump, New Approach.

Authors:  Sinan Sabit Kocabeyoglu; Umit Kervan; Dogan Emre Sert; Ertekin Utku Unal; Burcu Demirkan; Yesim Guray; Emre Aygun; Osman Fehmi Beyazal; Mehmet Karahan; Mustafa Pac
Journal:  Artif Organs       Date:  2018-11-04       Impact factor: 3.094

2.  Implantation of a centrifugal pump as a left ventricular assist device through a novel, minimized approach: upper hemisternotomy combined with anterolateral thoracotomy.

Authors:  Jan D Schmitto; Ulrich Molitoris; Axel Haverich; Martin Strueber
Journal:  J Thorac Cardiovasc Surg       Date:  2011-09-07       Impact factor: 5.209

3.  Comparison of temporary ventricular assist devices and extracorporeal life support in post-cardiotomy cardiogenic shock.

Authors:  Prashant N Mohite; Anton Sabashnikov; Achim Koch; Raj Binu; Ashok Padukone; Sundip Kaul; Olaf Maunz; Diana García-Sáez; Bartlomiej Zych; Mubassher Husain; Fabio De Robertis; Aron-Frederik Popov; André R Simon
Journal:  Interact Cardiovasc Thorac Surg       Date:  2018-12-01

4.  Minimally Invasive Implantation of Continuous Flow Left Ventricular Assist Devices: The Evolution of Surgical Techniques in a Single-Center Experience.

Authors:  Massimiliano Carrozzini; Jonida Bejko; Alvise Guariento; Maurizio Rubino; Roberto Bianco; Vincenzo Tarzia; Dario Gregori; Tomaso Bottio; Gino Gerosa
Journal:  Artif Organs       Date:  2018-10-28       Impact factor: 3.094

5.  A continuous-flow external ventricular assist device for cardiogenic shock: Evolution over 10 years.

Authors:  Masahiko Ando; Arthur R Garan; Hiroo Takayama; Veli K Topkara; Jiho Han; Paul Kurlansky; Melana Yuzefpolskaya; Maryjane A Farr; Paolo C Colombo; Yoshifumi Naka; Koji Takeda
Journal:  J Thorac Cardiovasc Surg       Date:  2018-02-13       Impact factor: 5.209

6.  Left ventricular assist device outflow graft: alternative sites.

Authors:  Magdy M El-Sayed Ahmed; Muhammad Aftab; Steve K Singh; Hari R Mallidi; Oscar H Frazier
Journal:  Ann Cardiothorac Surg       Date:  2014-09

7.  Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.

Authors:  Jonathan A Yang; Tomoko S Kato; Brittney P Shulman; Hiroo Takayama; Maryjane Farr; Ulrich P Jorde; Donna M Mancini; Yoshifumi Naka; P Christian Schulze
Journal:  J Heart Lung Transplant       Date:  2012-03-28       Impact factor: 10.247

8.  Clinical Outcomes of Advanced Heart Failure Patients with Cardiogenic Shock Treated with Temporary Circulatory Support Before Durable LVAD Implant.

Authors:  Palak Shah; Sara Smith; Jonathan W Haft; Shashank S Desai; Nelson A Burton; Matthew A Romano; Keith D Aaronson; Francis D Pagani; Jennifer A Cowger
Journal:  ASAIO J       Date:  2016 Jan-Feb       Impact factor: 2.872

9.  Minimally Invasive Left Ventricular Assist Device Implantation: A Comparative Study.

Authors:  Prashant N Mohite; Anton Sabashnikov; Binu Raj; Rachel Hards; Gemma Edwards; Diana García-Sáez; Bartlomiej Zych; Mubassher Husain; Anand Jothidasan; Javid Fatullayev; Mohamed Zeriouh; Alexander Weymann; Aron-Frederik Popov; Fabio De Robertis; André R Simon
Journal:  Artif Organs       Date:  2018-11-15       Impact factor: 3.094

10.  Minimally invasive surgery improves outcome of left ventricular assist device surgery in cardiogenic shock.

Authors:  Leonhard Wert; Anamika Chatterjee; Günes Dogan; Jasmin S Hanke; Dietmar Boethig; Kirstin A Tümler; L Christian Napp; Dominik Berliner; Christina Feldmann; Christian Kuehn; Andreas Martens; Malakh L Shrestha; Axel Haverich; Jan D Schmitto
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.